Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Fibrosis × Thoracic × Clear all

Phase

Phase NA 1 Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 52 Carcinoma, Non-Small-Cell Lung 42 Breast Neoplasms 18 Pancreatic Neoplasms 11 Small Cell Lung Carcinoma 9 Ovarian Neoplasms 8 Melanoma 8 Colorectal Neoplasms 8 Colonic Neoplasms 8 Stomach Neoplasms 7 Sarcoma 6 Head and Neck Neoplasms 6 Neoplasms 5 Carcinoma, Renal Cell 5 Urinary Bladder Neoplasms 4 Pleural Effusion, Malignant 4 Mesothelioma 4 Adenocarcinoma of Lung 4 Uterine Cervical Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Prostatic Neoplasms 3 Osteosarcoma 3 Glioblastoma 3 Esophageal Neoplasms 3 Carcinoma, Hepatocellular 3 Rectal Neoplasms 2 Neoplasm Metastasis 2 NSCLC 2 Mesothelioma, Malignant 2 Liver Neoplasms 2

Interventions

4-((5-chloro-2-pyridinyl)oxy)-1-((((4S)-4-methyl-2,5-dioxo-4-imidazolidinyl)methyl)sulfonyl)-piperidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02604862 2020-02-13

FIB ONE

University of Edinburgh

Phase EARLY_PHASE1 Completed

Fibrosis, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡